Core Viewpoint - A securities fraud class action lawsuit has been filed against DeFi Technologies Inc. for alleged misrepresentations regarding the company's revenue guidance for fiscal year 2025, affecting investors who purchased securities between May 12, 2025, and November 14, 2025 [4]. Group 1 - The lawsuit was initiated in the United States District Court for the Eastern District of New York on behalf of investors who acquired DeFi Technologies securities during the specified period [4]. - The allegations include violations of the Securities Exchange Act of 1934 by the company and certain senior officers [4]. - Investors are reminded of the deadline to file as lead plaintiff by January 30, 2026, with the option to remain an absent class member if no action is taken [5]. Group 2 - Bernstein Liebhard LLP, the law firm handling the case, has a history of recovering over $3.5 billion for clients and has been recognized for its success in litigating class actions [6].

Legal Analysis: Compounded Deception & Financial Causation The complaint details how two distinct, undisclosed operational failures corrected the market's misperception of Stride's true financial health, leading to the massive loss of market capitalization. | Alleged | | | | --- | --- | --- | | Fraudulent | Allegation & Financial Impact | Key Legal Issues | | Mechanism | | | | / Event | | | | First | Allegedly retained "Ghost Students" on the | Whether the Company Misrepresented Core | | Alleged | books to ...

Core Viewpoint - A class action lawsuit has been filed against Freeport-McMoRan Inc. and certain senior executives for securities fraud, following significant stock drops attributed to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the District of Arizona, captioned Reed v. Freeport-McMoRan Inc., et al., No. 2:25-cv-04243, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [3]. - Investors have until January 12, 2026, to request to be appointed to lead the case [3]. Group 2: Company Operations and Safety Claims - Freeport-McMoRan operates the Grasberg Copper and Gold Mine in Indonesia through its affiliate PT Freeport Indonesia, where the Indonesian government holds a commercial interest [4]. - The company has been accused of overstating its commitment to safety, as unsafe mining practices at the Grasberg mine were likely to result in worker fatalities [5]. Group 3: Stock Price Impact - On September 9, 2025, Freeport's stock dropped by $2.77 per share (over 5.9%) following a press release about the suspension of mining operations due to a landslide that trapped seven team members [6]. - Following an update on September 24, 2025, indicating two fatalities and five missing individuals, the stock fell by $7.69 per share (almost 17%) [7]. - On September 25, 2025, reports of strained relations with the Indonesian government led to a further decline of $2.33 per share (over 6%) [8]. - An Indonesian news report on September 28, 2025, suggested that the landslide was preventable, further impacting investor confidence [9].

Core Viewpoint - Klarna Group plc is under investigation for potential violations of federal securities laws and unlawful business practices following disappointing Q3 2025 financial results that led to a significant drop in share price [1][3]. Group 1: Company Overview - Klarna launched its IPO in September 2025, selling 34,311,274 shares at a price of $40.00 per share [3]. - The company reported a substantial increase in the provision for credit losses in its Q3 2025 financial results [3]. Group 2: Financial Impact - Following the announcement of Q3 results, Klarna's share price fell by $3.25, or approximately 9.3%, from $34.88 on November 17, 2025, to close at $31.63 on November 18, 2025 [3].

NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- NEW YORK, December 4, 2025 – Levi & Korsinsky, LLP notifies investors in StubHub Holdings, Inc. ("StubHub Holdings, Inc." or the "Company") (NYSE: STUB) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of StubHub Holdings, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of persons and entities that purchased or otherwise acquired StubHub common stock pursuant and ...

Core Viewpoint - A class action securities lawsuit has been filed against Perrigo Company plc, alleging securities fraud that affected investors between February 27, 2023, and November 4, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that Perrigo's acquisition of the infant formula business from Nestlé was significantly underinvested in maintenance and operational improvements [2]. - It is alleged that Perrigo needed to incur substantial capital and operational expenditures beyond previously stated cost estimates to address issues in the infant formula business [2]. - The complaint points out significant manufacturing deficiencies in the facility related to the infant formula business [2]. - As a result of these issues, Perrigo's financial results, including earnings and cash flow, were reportedly overstated [2]. - The positive statements made by the defendants regarding the Company's business and prospects were claimed to be materially misleading and lacked a reasonable basis [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until January 16, 2026, to request appointment as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].

NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Skye Bioscience, Inc. ("Skye Bioscience, Inc." or the "Company") (NASDAQ: SKYE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Skye Bioscience, Inc. investors who were adversely affected by alleged securities fraud between November 4, 2024 and October 3, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/p ...

Core Viewpoint - A class action lawsuit has been filed against Synopsys, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Northern District of California, titled Kim v. Synopsys, Inc., et al., No. 3:25-cv-09410 [3]. - Investors have until December 30, 2025, to request to lead the case [3]. - The complaint alleges violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of Synopsys investors [3]. Group 2: Company Performance - Synopsys provides design automation software products, with its Design IP segment being the fastest-growing, increasing from 25% of revenue in 2022 to 31% in 2024 [4]. - The company previously claimed that customers relied on its IP to minimize integration risk and speed time to market, and reported strength in Europe and South Korea [5]. Group 3: Financial Impact - On September 9, 2025, Synopsys reported Q3 2025 results, revealing a 7.7% year-over-year decline in Design IP revenue to $425.9 million and a 43% year-over-year decline in net income to $242.5 million [6]. - The company indicated that customers required more customization for IP components, which negatively impacted the economics of its Design IP business [6]. - Following the financial results, Synopsys stock fell nearly 36%, from $604.37 per share to $387.78 per share [6].

INSPIRE STOCK ALERT: Inspire Medical Systems, Inc. (INSP) Investors Reminded to Contact BFA Law Prior to the January 5 Deadline in Securities Fraud Class ActionDecember 03, 2025 3:36 PM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - December 3, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for securiti ...

Group 1 - The Law Offices of Frank R. Cruz is investigating Acadia Healthcare Company, Inc. for potential violations of federal securities laws [1] - The investigation is initiated on behalf of investors who may have lost money on Acadia Healthcare Company, Inc. [1] - Investors are encouraged to inquire about pursuing claims to recover their losses [1]